WithdrawnNCT06213298
Effect of Kava on Anxiety and Stress in Cancer Survivors
Medication studyAges 18+United States
Understand this study
Who could participate?
Listed age limits: from 18 years.
- Listed locations
- MinneapolisSee all locations and recruitment
- Study phase
- Early phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
What to know before participating
A point to clarify
This summary does not cover all risks or eligibility requirements. What risks or changes to my care would apply to me?
Things to check before joining
Study start dateStarted: June 20, 2024
- Recruitment status
- Withdrawn
- Enrollment listed in the registry
- 0
- Sponsor
- Masonic Cancer Center, University of Minnesota
- Sponsor type
- University
- Study type
- Drug
- Intervention type
- Dietary supplement, Drug
- Study phase
- Early Phase 1An early first-in-human or very early safety study, usually focused on how a treatment behaves in the body.
- Locations
- United States
- Age range
- Over 18 Years
- Official registry ID
- NCT06213298
- Official title
Show the full official title
Effect of Kava on Anxiety and Stress in Cancer Survivors
Recruitment & locations
WithdrawnThis badge reflects the study status reported by the registry. Check the registry for the latest information.
Minneapolis
Interested in joining this study?
Questions about this study
Who is behind this study?
The study sponsor is Masonic Cancer Center, University of Minnesota, a university.
Does this study involve medication?
Yes. The study involves medication, including Kava.
Who can participate?
Listed age limits: from 18 years.
Is this study still recruiting?
The registry lists this study as withdrawn.
